Oval Medical CEO Barbara Lead CEO will be supporting the Aurora Project – an initiative focused on patient centricity and patients as partners. The project will be meeting at eyeforpharma in Barcelona from the 14-16 March. Find out more about the project at the following link: https://lnkd.in/gVTtx6
Author Archive | ovalmedical
Members of the Oval and SMC Ltd. team will be attending the Drug Delivery Partnership (DDP) conference in Palm Beach Gardens, FL February 7-9, 2017. If you or someone you know is attending and would like to learn about the next generation of auto injectors, manufacturing scale-up, or production of combination products please let […]
Oval and SMC Ltd. will be exhibiting at Pharmapack Europe in Paris, France. Visit us at booth #L24 to meet members of our Oval Medical Technologies team and learn about the next generation of auto injectors, manufacturing scale-up, and production of combination products.
Oval Medical will exhibit and present 2 posters at the PDA Universe of Pre-filled Syringes and Injection Devices 2016 in Huntington Beach on October 17 & 18. You will have an opportunity to connect with us in Booth 503 or at the poster display area. In case you would like to pre-arrange a meeting with […]
Oval Medical representatives Matthew Young (CTO), Pete Evans (Dir. Device Development) and Bastiaan de Leeuw (Dir. Business Development) will attend Pharmapack Europe (Paris, 10-11 Feb 2016). Our autoinjector products will be on display at booth #537 of our Japanese partner company Solize. If you would like to set up an appointment with one of us, […]
Barbara Lead (CEO) and Matthew Young (CTO) will be present at Biotech Showcase 2016 from Jan 11th-13th (https://lnkd.in/e7-gUTh) in San Francisco. To arrange to meet them you can contact us via our Contact page.
Oval Medical’s partner Solize Corporation will exhibit and present at the InnoPack 2015 conference in Tokyo (April 22-24th) in conjunction with the CPhI event held at TokyoBigSight. Representatives from Oval and Solize will be present to demonstrate the Oval autoinjectors and collaboration opportunities. Oval Medical has been attending and exhibiting at a number of conferences […]
April 2015 Oval Medical completes Innovate UK (formerly The Technology Strategy Board) Smart Award Grant for development of manufacturing equipment for their novel container closure system. Oval Medical has developed bespoke sealing equipment for the drug container in collaboration with 3P Limited; this is a key manufacturing step for its leading edge auto injector. Commenting […]
March 2015 Oval Medical recently completed a £1.5m rights issue for the development of the manufacturing process for its novel autoinjector. The autoinjector facilitates the delivery of the new generation of biologics by eliminating issues including glass breakage, drug contamination and variable injection times. This equipment will form part of the manufacturing process for clinical […]
November 2014 Oval Medical received £25,000 to contribute to market research for its new, innovative epinephrine autoinjector for the treatment of anaphylactic shock. The incidence of allergies that can cause this serious and potentially fatal reaction is growing worldwide. Oval’s epinephrine autoinjector incorporates the same design philosophy as the first device being used for sumatriptan. […]